353
Participants
Start Date
August 7, 2018
Primary Completion Date
May 10, 2022
Study Completion Date
February 24, 2023
Nalbuphine ER Tablets
Active Nalbuphine ER Tablets
Placebo Tablets
Placebo matching NAL ER with no active substance
Study Site 402, Linz
Study Site 401, Graz
Study Site 216, Berlin
Study Site 209, Berlin
Study Site 208, Berlin
Study Site 134, Stony Brook
Study Site 132, Hershey
Study Site 106, Philadelphia
Study Site 128, Washington D.C.
Study Site 215, Hamburg
Study Site 102, Rockville
Study Site 222, Hamburg
Study Site 214, Kiel
Study Site 148, Morgantown
Study Site 101, Wilmington
Study Site 147, Charleston
Study Site 501, Brest
Study Site 158, Orlando
Study Site 108, South Miami
Study Site 138, Boca Raton
Study Site 142, Tampa
Study Site 303, Rzeszów
Study Site 140, Chattanooga
Study Site 145, Knoxville
Study Site 221, Düsseldorf
Study Site 120, Cleveland
Study Site 122, Cincinnati
Study Site 139, Troy
Study Site 143, Ann Arbor
Study Site 202, Münster
Study Site 205, Bad Bentheim
Study Site 302, Wroclaw
Study Site 219, Cologne
Study Site 201, Mainz
Study Site 204, Frankfurt am Main
Study Site 118, Saint Joseph
Study Site 212, Heidelberg
Study Site 206, Stuttgart
Study Site 502, Paris
Study Site 103, Webster
Study Site 137, Austin
Study Site 220, München
Study Site 150, West Jordan
Study Site 151, Phoenix
Study Site 144, Henderson
Study Site 146, Las Vegas
Study Site 141, North Hollywood
Study Site 157, Laguna Niguel
Study Site 130, San Francisco
Study Site 121, Fremont
Study Site 135, Spokane
Study Site 136, Boston
Study Site 153, Brighton
Study Site 109, Portsmouth
Study Site 159, Hackensack
Study Site 131, Johnston
Study Site 107, Charleston
Study Site 213, Dresden
Study Site 304, Bialystok
Study Site 306, Katowice
Study Site 308, Krakow
Study Site 316, Krakow
Study Site 309, Lodz
Study Site 314, Lublin
Study Site 305, Ostrowiec Świętokrzyski
Study Site 313, Poznan
Study Site 315, Poznan
Study Site 310, Warsaw
Study Site 301, Warsaw
Study Site 312, Warsaw
Lead Sponsor
Trevi Therapeutics
INDUSTRY